Skip to Content

Zamansky LLC Investigates Rockwell Medical Technologies for Possible Federal Securities Laws Violations

May 7, 2013 In The News

Zamansky LLC notifies all investors in Rockwell Medical Technologies Inc., the biopharmaceutical company, for possible violations of federal securities laws over its publis statements and representations about the progress of Soluble Ferric Pyrophosphate (“SFP”), an experimental iron-therapy drug intended to treat iron-deficiency.
Read the full Press Release